Related Experiment Videos
[Chemoembolization techniques for hepatocellular carcinoma in cirrhosis]
D Vetter1, J P Bronowicki, M Doffoël
1Service d'Hépato-Gastroentérologie, Hôpitaux Universitaires de Strasbourg, Hôpital Civil.
Annales De Chirurgie
|September 30, 1998
Summary
Transcatheter oily chemoembolization is a leading palliative treatment for advanced hepatocellular carcinoma. This effective therapy offers improved survival rates for patients ineligible for liver transplantation.
Area of Science:
- Hepatobiliary Medicine
- Interventional Radiology
- Oncology
Context:
- Hepatocellular carcinoma (HCC) is increasingly prevalent, often diagnosed at advanced stages.
- Liver transplantation, a curative option, is not feasible for many HCC patients due to disease extent.
- Loco-regional palliative therapies are crucial for managing advanced HCC.
Purpose:
- To highlight transcatheter oily chemoembolization as the primary therapy for loco-regional palliative treatment of HCC.
- To differentiate this technique from less effective chemoembolization methods.
- To present survival data and ongoing validation of this treatment modality.
Summary:
- Transcatheter oily chemoembolization is the most utilized therapy for loco-regional palliative treatment of hepatocellular carcinoma.
- This method is indicated for advanced HCC when radical treatments like liver transplantation are precluded.
- Current techniques yield 1-year and 5-year survival rates of 60% and 30%, respectively, with ongoing confirmation via a randomized trial.
Impact:
- Provides a vital palliative treatment option for advanced hepatocellular carcinoma patients.
- Improves survival outcomes for individuals unsuitable for liver transplantation.
- Establishes a benchmark for loco-regional therapy in HCC management, pending further trial validation.